Andre Bosly
Yvoir, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 05, 2022
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.
Journal: Cell metabolism
Published: September 21, 2018
Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study.
Journal: Leukemia & lymphoma
Published: January 18, 2018
Unmet needs in the scientific approach to older patients with lymphoma.
Journal: Haematologica
Published: June 02, 2017
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 21, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 30, 2017
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Journal: Lancet (London, England)
Published: June 18, 2016
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 23, 2015
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma.
Journal: The oncologist
Published: October 10, 2013
BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma.
Journal: The Lancet. Oncology
Published: August 17, 2013
Last Updated: 09/26/2026